ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

KALY Kali Inc (CE)

0.000001
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Kali Inc (CE) USOTC:KALY OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

KALY - Kali Inc Introduces HEMP4MULA CBD Infused Candies and Vapes Into $22 Billion Hemp-Derived CBD Market

06/12/2018 2:38pm

InvestorsHub NewsWire


Dallas, TX -- December 6, 2018 -- InvestorsHub NewsWire -- Kali, Inc. (USOTC: KALY) (“KALY”) today announced launching its own line of hemp-derived CBD infused candies and vapes under the brand name HEMP4MULA.  With an initial wholesale order pending KALY’s completion of its first production run, the company expects to see HEMP4MULA CBD Gum on sale at retail later this month.  Mints and gummies infused with CBD are expected to follow soon thereafter.  HEMP4MULA vapes are also coming soon. 

KALY recently acquired a biotech company with a patented cannabis extraction process.  Accordingly, KALY updated its overall business plan (a presentation on the company’s updated business plan is available on KALY’s website).  HEMP4MULA is part of the updated business plan which management is rapidly executing with first revenue from the updated business plan anticipated before the end of this year.  Revenue is anticipated from the initial HEMP4MULA CBD Gum sale, and from KALY’s custom formulation of hemp-derived CBD concentrates to support KALY’s US Cannabis Health partner, Puration, Inc. (USOTC: PURA), in producing a private labeled CBD Infused Water for Generex Biotechnology, (OTCQB: GNBT).

The following is an excerpt from an article recently published by The Motley Fool about the potential to be garnered from the pending passage of the 2018 Farm Act expected to include the legalization of hemp farming:
 
"If the bill makes it through Congress and is signed by President Trump, as widely expected, industrial hemp should be legal on Jan. 1, 2019. If this occurs, the U.S. market for hemp -- and its derivatives -- is expected to soar. The hemp-derived CBD market is projected to rocket from about $591 million this year to $22 billion by 2022, according to the Brightfield Group. That's a whopping 37-fold increase in just four years!" 


To learn more about the company visit https://www.kali-extracts.com/

Check back frequently to the company’s website and to the OTCMarkets website for more updates coming soon as management populates the new company website with additional information and brings all corporate information current on the OTCMarkets website.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT:
Kali, Inc.
941.444.6994
management@wavemarineservices.com

 

1 Year Kali (CE) Chart

1 Year Kali (CE) Chart

1 Month Kali (CE) Chart

1 Month Kali (CE) Chart

Your Recent History

Delayed Upgrade Clock